Geron Q4 EPS $(0.09) Beats $(0.10) Estimate, Sales $23.00K Miss $70.00K Estimate; $378.1M In Cash, Cash Equivalents, And Marketable Securities Projected To Fund Operating Expenses Into The Third Quarter Of 2025
Portfolio Pulse from Benzinga Newsdesk
Geron (NASDAQ:GERN) reported Q4 earnings with a loss of $(0.09) per share, beating the $(0.10) estimate. However, sales of $23K missed the $70K estimate significantly. The company has $378.1M in cash and equivalents, expected to fund operations into Q3 2025.
February 28, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Geron reported a smaller than expected Q4 loss per share but missed sales estimates. It has a strong cash position to fund future operations.
The mixed earnings report with a better-than-expected loss per share but disappointing sales figures could lead to a neutral short-term impact on GERN's stock price. The strong cash position is a positive, but the sales miss may raise concerns.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100